Purchase Order 75F40119P10384
Award Date 7/12/19
Potential Completion Date 12/31/19
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey. The contract is for the provision of monoclonal antibody (mAb) development services, with a completion date of September 19, 2025, and a ceiling value of $13,062.24. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that specializes in advanced...
- The U.S. government awarded a $12,411.55 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2021, for animal immunization, cell fusion, subcloning, antibody production, purification, and sequencing services. The contract, which was completed on March 16, 2022, was funded through a civilian federal agency within the Southeast Area and performed at Genscript's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award, valued at $24,999.00, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract requires Genscript to generate four stable cell lines, with a final completion date of March 11, 2022. This was a firm fixed-price purchase order, and there was no set-aside designation. Genscript has received...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to GenScript USA Inc., a for-profit biotechnology company, to provide custom monoclonal antibody production services. The $13,758.30 contract has an October 16, 2019 completion date and was awarded on August 14, 2019. GenScript, based in Piscataway, New Jersey, specializes in gene synthesis, protein production, and other...
- This contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, provides Genscript USA Inc. with $137,250.00 to deliver monoclonal antibodies and plasmid services. The firm-fixed price purchase order has an ultimate completion date of August 31, 2025. Genscript USA Inc. is a biotechnology company in Piscataway, New Jersey that specializes in molecular biology products and services for federal agencies....
- The National Institute of Environmental Health Sciences awarded a $21,993.84 Firm Fixed Price call order to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, on September 18, 2019. This contract modification was issued under a Blanket Purchase Agreement to back out unused FY2019 funds that were expiring, with an ultimate completion date of July 1, 2024. The award carries no set-aside designation and represents a call against an existing BPA vehicle rather than a...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- The U.S. government awarded a purchase order contract valued at $4,076.85 to Genscript USA Inc. for monoclonal antibody production. The contract, awarded on April 27, 2016, with an ultimate completion date of July 28, 2016, utilized firm fixed price pricing with no set-aside designation. Work was performed at Genscript's facility in Piscataway, New Jersey, and the funding agency was a civilian federal entity within the Southeast Area region. Genscript USA Inc. is a biotechnology company...